| Financial Year |
March 31 2023 |
| Monetary Funds |
978,103,928.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
604,397,028.03 |
| Accounts Receivable |
826,632,647.79 |
| Advances to Suppliers |
25,973,032.86 |
| Other Receivables |
25,373,000.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
255,884,811.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,394,483.41 |
| Total Current Assets |
2,918,828,139.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
36,635,064.04 |
| Fixed Assetes |
642,393,519.37 |
| Under-construction Projects |
42,885,150.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
119,516,257.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
390,278.07 |
| Deferred Income Tax Assets |
13,662,285.55 |
| Other Non-Current Assets |
5,847,108.00 |
| Sub-Total of Non-Current Assets |
861,950,207.24 |
| Total Assets |
3,780,778,346.61 |
| Short-Term Loans |
3,464,438.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
151,412,666.48 |
| Accounts Payable |
251,228,825.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,697,051.94 |
| Taxes Payable |
29,873,461.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
84,312,174.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,762,274.05 |
| Other Current Liabilities |
25,263,955.57 |
| Sub-Total of Current Liabilities |
782,136,363.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,382,806.42 |
| Other Non-Current Liabilities |
6,428,571.44 |
| Sub-Total of Non-Current Liabilities |
19,216,106.25 |
| Total Liabilities |
801,352,469.99 |
| Paid-In Capital(Or Share Stock) |
506,332,586.00 |
| Capital Surplus |
443,406,479.20 |
| Surplus Reserve |
339,518,050.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,690,892,502.56 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,979,425,876.62 |
| Owner's Equity（Stockholder's Equity） |
2,979,425,876.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,780,778,346.61 |
